220 related articles for article (PubMed ID: 24413153)
1. Lats2 is critical for the pluripotency and proper differentiation of stem cells.
Aylon Y; Sarver A; Tovy A; Ainbinder E; Oren M
Cell Death Differ; 2014 Apr; 21(4):624-33. PubMed ID: 24413153
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.
Qin H; Blaschke K; Wei G; Ohi Y; Blouin L; Qi Z; Yu J; Yeh RF; Hebrok M; Ramalho-Santos M
Hum Mol Genet; 2012 May; 21(9):2054-67. PubMed ID: 22286172
[TBL] [Abstract][Full Text] [Related]
3. RASSF1A uncouples Wnt from Hippo signalling and promotes YAP mediated differentiation via p73.
Papaspyropoulos A; Bradley L; Thapa A; Leung CY; Toskas K; Koennig D; Pefani DE; Raso C; Grou C; Hamilton G; Vlahov N; Grawenda A; Haider S; Chauhan J; Buti L; Kanapin A; Lu X; Buffa F; Dianov G; von Kriegsheim A; Matallanas D; Samsonova A; Zernicka-Goetz M; O'Neill E
Nat Commun; 2018 Jan; 9(1):424. PubMed ID: 29382819
[TBL] [Abstract][Full Text] [Related]
4. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
Aylon Y; Ofir-Rosenfeld Y; Yabuta N; Lapi E; Nojima H; Lu X; Oren M
Genes Dev; 2010 Nov; 24(21):2420-9. PubMed ID: 21041410
[TBL] [Abstract][Full Text] [Related]
5. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
[TBL] [Abstract][Full Text] [Related]
6. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa.
Molina-Castro SE; Tiffon C; Giraud J; Boeuf H; Sifre E; Giese A; Belleannée G; Lehours P; Bessède E; Mégraud F; Dubus P; Staedel C; Varon C
Cell Mol Gastroenterol Hepatol; 2020; 9(2):257-276. PubMed ID: 31669263
[TBL] [Abstract][Full Text] [Related]
7. Activation of DNA damage response signaling in mouse embryonic stem cells.
Chuykin IA; Lianguzova MS; Pospelova TV; Pospelov VA
Cell Cycle; 2008 Sep; 7(18):2922-8. PubMed ID: 18787397
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of folate deficiency-induced apoptosis in mouse embryonic stem cells: Cell cycle arrest/apoptosis in G1/G0 mediated by microRNA-302a and tumor suppressor gene Lats2.
Liang Y; Li Y; Li Z; Liu Z; Zhang Z; Chang S; Wu J
Int J Biochem Cell Biol; 2012 Nov; 44(11):1750-60. PubMed ID: 22828209
[TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.
Aylon Y; Michael D; Shmueli A; Yabuta N; Nojima H; Oren M
Genes Dev; 2006 Oct; 20(19):2687-700. PubMed ID: 17015431
[TBL] [Abstract][Full Text] [Related]
10. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
11. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y
Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236
[TBL] [Abstract][Full Text] [Related]
12. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.
Paramasivam M; Sarkeshik A; Yates JR; Fernandes MJ; McCollum D
Mol Biol Cell; 2011 Oct; 22(19):3725-33. PubMed ID: 21832154
[TBL] [Abstract][Full Text] [Related]
13. Lats2 modulates adipocyte proliferation and differentiation via hippo signaling.
An Y; Kang Q; Zhao Y; Hu X; Li N
PLoS One; 2013; 8(8):e72042. PubMed ID: 23977200
[TBL] [Abstract][Full Text] [Related]
14. Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73.
Kawahara M; Hori T; Chonabayashi K; Oka T; Sudol M; Uchiyama T
Blood; 2008 Nov; 112(9):3856-66. PubMed ID: 18565851
[TBL] [Abstract][Full Text] [Related]
15. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.
Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM
Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485
[TBL] [Abstract][Full Text] [Related]
17. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.
Szymaniak AD; Mi R; McCarthy SE; Gower AC; Reynolds TL; Mingueneau M; Kukuruzinska M; Varelas X
Elife; 2017 May; 6():. PubMed ID: 28492365
[TBL] [Abstract][Full Text] [Related]
18. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 2-associating protein 1 commits murine embryonic stem cell differentiation through retinoblastoma protein regulation.
Kim Y; Deshpande A; Dai Y; Kim JJ; Lindgren A; Conway A; Clark AT; Wong DT
J Biol Chem; 2009 Aug; 284(35):23405-14. PubMed ID: 19564334
[TBL] [Abstract][Full Text] [Related]
20. LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma.
Guo C; Liang C; Yang J; Hu H; Fan B; Liu X
Oncol Rep; 2019 May; 41(5):2753-2761. PubMed ID: 30896861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
